NCT05559164 2025-11-14
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Rutgers, The State University of New Jersey
Phase 2 Recruiting
Clinical Trials
13 trialsNCT02958852 2025-09-10
ABC-SE
Lund University Hospital
Phase 2 Completed
NCT03872388 2024-10-02
Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01980823 2023-08-30
Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer
Columbia University
Phase EARLY_PHASE1 Completed
NCT05103644 2022-11-02
Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"
Beni-Suef University
Phase 2/3 Unknown
NCT02201381 2022-07-18
METRICS
Health Clinics Limited
Phase 3 Withdrawn
NCT01988571 2022-01-04
Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)
Wake Forest University Health Sciences
Phase 2 Completed
NCT04601116 2021-01-14
The MASTER Study (MAmmary Cancer STatin ER Positive Study)
Aarhus University Hospital
Phase 3 Recruiting
NCT02674204 2019-05-15
STOP
Cedars-Sinai Medical Center
Phase 2 Terminated
NCT00637481 2016-12-29
A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT02416427 2015-04-15
TRINACRIA
Regina Elena Cancer Institute
Phase 2 Unknown
NCT00816244 2012-04-13
Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer
Lund University Hospital
Phase 2 Completed
NCT00914017 2010-02-11
Statins and Breast Cancer Biomarkers
University of Vermont
Phase 2 Unknown